Abstract
To evaluate lymphopenia as a marker for coronavirus disease severity, we conducted a meta-analysis of 10 studies. Severe illness was associated with lower lymphocyte and higher leukocyte counts. Using these markers for early identification of patients with severe disease may help healthcare providers prioritize the need to obtain therapy.
Cite
CITATION STYLE
APA
Huang, G., Kovalic, A. J., & Graber, C. J. (2020). Prognostic value of leukocytosis and lymphopenia for coronavirus disease severity. Emerging Infectious Diseases, 26(8), 1839–1841. https://doi.org/10.3201/eid2608.201160
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free